MIM
CVS icon

Marco Investment Management’s CVS Health CVS Stock Holding History

Marco Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.32M Sell
74,121
-490
-0.7% -$37.7K 0.4% 61
2025
Q4 		$5.92M Sell
74,611
-1,625
-2% -$128K 0.44% 59
2025
Q3 		$5.75M Buy
76,236
+1,805
+2% +$124K 0.44% 55
2025
Q2 		$5.13M Sell
74,431
-360
-0.5% -$23.6K 0.43% 56
2025
Q1 		$5.07M Sell
74,791
-720
-1% -$43.1K 0.47% 52
2024
Q4 		$3.39M Sell
75,511
-825
-1% -$46.3K 0.29% 74
2024
Q3 		$4.8M Sell
76,336
-1,786
-2% -$104K 0.41% 58
2024
Q2 		$4.61M Sell
78,122
-46,736
-37% -$2.92M 0.43% 57
2024
Q1 		$9.96M Sell
124,858
-20,340
-14% -$1.55M 0.94% 35
2023
Q4 		$11.5M Sell
145,198
-13,460
-8% -$958K 1.17% 31
2023
Q3 		$11.1M Buy
158,658
+49
+0% +$3.47K 1.27% 24
2023
Q2 		$11M Buy
158,609
+5,767
+4% +$410K 1.18% 27
2023
Q1 		$11.4M Buy
152,842
+2,355
+2% +$197K 1.28% 23
2022
Q4 		$14M Sell
150,487
-525
-0.3% -$50.7K 1.64% 18
2022
Q3 		$14.4M Buy
151,012
+1,520
+1% +$150K 1.83% 16
2022
Q2 		$13.9M Buy
149,492
+4,706
+3% +$459K 1.61% 18
2022
Q1 		$14.7M Sell
144,786
-8,584
-6% -$902K 1.49% 20
2021
Q4 		$15.8M Sell
153,370
-5,000
-3% -$462K 1.56% 18
2021
Q3 		$13.4M Buy
158,370
+6,958
+5% +$583K 1.48% 19
2021
Q2 		$12.6M Sell
151,412
-147
-0.1% -$12K 1.47% 20
2021
Q1 		$11.4M Buy
151,559
+6,037
+4% +$440K 1.49% 23
2020
Q4 		$9.94M Sell
145,522
-47,514
-25% -$3.09M 1.43% 25
2020
Q3 		$11.3M Buy
193,036
+5,996
+3% +$373K 1.85% 17
2020
Q2 		$12.2M Buy
187,040
+78,919
+73% +$4.97M 2.23% 12
2020
Q1 		$6.42M Buy
108,121
+7,864
+8% +$525K 1.36% 23
2019
Q4 		$7.45M Buy
100,257
+682
+0.7% +$47.9K 1.16% 23
2019
Q3 		$6.28M Buy
99,575
+53,497
+116% +$3.17M 1.07% 27
2019
Q2 		$2.51M Buy
46,078
+12,459
+37% +$671K 0.45% 66
2019
Q1 		$1.81M Sell
33,619
-6,608
-16% -$408K 0.34% 67
2018
Q4 		$2.64M Sell
40,227
-6,525
-14% -$487K 0.52% 57
2018
Q3 		$3.68M Sell
46,752
-22
-0% -$1.57K 0.52% 55
2018
Q2 		$3.01M Buy
46,774
+2,074
+5% +$137K 0.47% 59
2018
Q1 		$2.78M Buy
44,700
+275
+0.6% +$19.7K 0.43% 63
2017
Q4 		$3.22M Sell
44,425
-4,270
-9% -$310K 0.49% 60
2017
Q3 		$3.96M Hold
48,695
– – 0.62% 49
2017
Q2 		$3.92M Sell
48,695
-750
-2% -$59.2K 0.65% 51
2017
Q1 		$3.88M Sell
49,445
-1,150
-2% -$91.8K 0.66% 49
2016
Q4 		$3.99M Sell
50,595
-1,400
-3% -$113K 0.7% 46
2016
Q3 		$4.63M Sell
51,995
-39
-0.1% -$3.68K 0.83% 44
2016
Q2 		$4.98M Sell
52,034
-250
-0.5% -$24.9K 0.93% 37
2016
Q1 		$5.42K Sell
52,284
-1,800
-3% -$175K 0.78% 32
2015
Q4 		$5.29M Buy
54,084
+1,250
+2% +$122K 0.98% 34
2015
Q3 		$5.1M Buy
52,834
+1,225
+2% +$129K 1.01% 32
2015
Q2 		$5.41M Buy
51,609
+700
+1% +$71.5K 0.9% 41
2015
Q1 		$5.25M Buy
50,909
+425
+0.8% +$43K 0.91% 41
2014
Q4 		$4.86M Sell
50,484
-640
-1% -$56.4K 0.61% 45
2014
Q3 		$4.07M Sell
51,124
-3,325
-6% -$262K 0.56% 48
2014
Q2 		$4.1M Sell
54,449
-800
-1% -$60.5K 0.78% 47
2014
Q1 		$4.13M Buy
55,249
+3,100
+6% +$219K 0.86% 42
2013
Q4 		$3.73K Sell
52,149
-2,875
-5% -$185K 0.2% 46
2013
Q3 		$3.12M Buy
55,024
+312
+0.6% +$18.6K 0.72% 53
2013
Q2 		$3.13M Buy
+54,712
New +$3.17M 0.91% 39

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marco Investment Management's CVS Position: Q1 2026 in Review

Marco Investment Management reduced its CVS Health (CVS) stake by 0.66% in Q1 2026, selling an estimated $37.7K and leaving 74,121 shares worth $5.32M. The position accounts for 0.4% of the portfolio, ranked #61.

Marco Investment Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.8M in Q4 2021. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Marco Investment Management held 74,121 shares of CVS Health worth $5.32M as of Q1 2026.
  • Marco Investment Management sold 490 CVS Health shares in Q1 2026, an estimated $37.7K.
  • CVS Health made up 0.4% of Marco Investment Management's portfolio in Q1 2026, its #61 holding.
  • Marco Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Marco Investment Management's CVS Health position peaked at $15.8M in Q4 2021.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Marco Investment Management's 13F filing for Q1 2026, filed 8 May 2026.